Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 57 for “"Cefepime"”.
-
Efeito da dose de cefepime, piperacilina-tazobactam e meropenem na mortalidade de pacientes com infecção da corrente sanguínea por enterobactérias
… com bacteremia por enterobactérias tratados com cefepime, piperacilina-tazobactam ou meropenem em um estudo de coorte prospectivo. Posologia dos antibióticos foi classificada em otimizada, apropriada e potencialmente inapropriada. Resultados: Cinquenta e dois (52%) episódios foram causados por E. …
-
Ο ρόλος των αντιβιοτικών στην οξεία παγκρεατίτιτδα και οι παράγοντες που επηρεάζουν την ιστική συγκέντρωση τους στο πάγκρεας: συμπεράσματα φαρμακοκινητικής μελέτης της κεφεπίμης σε φυσιολογικά κουνέλια και κουνέλια με οξεία νεκρωτική παγκρεατίτιδα
… study the pharmacodynamic characteristics of cefepime (a fourth generation cephalosporin) in acute necrotizing pancreatitis, are investigated for the first time in literature. Therefore, normal rabbits (group A) and rabbits with ethionine induced acute necrotizing pancreatitis received …
-
Drug/inflammation nutrient transport interaction in the lactating mother-neonate dyad
… dyad. The overall hypothesis was that cefepime would inhibit L-carnitine transport at the lactating mammary gland and in developing neonates. Additionally, inflammation would alter energy substrate transporter expression in mammary tissue. The first objective was to investigate the …
-
The effect of the efflux pump inhibitor Carbonyl Cyanide m- Chlorophenylhydrazone (CCCP) on the susceptibility to imipenem and cefepime in clinical strains of Acinetobacter Baumannii
… sobre la actividad bactericida de imipenem y cefepime en cepas de A. baumannii Métodos: 49 cepas aisladas como A. baumannii fueron obtenidas en el Hospital Regional de Cajamarca. Mediante técnicas moleculares en el laboratorio de Biología Molecular de la Universidad Peruana de Ciencias …
-
Directed molecular evolution of fourth-generation cephalosporin resistance in
<p>Cefepime is a fourth-generation cephalosporin approved by the FDA in 1996 (Barlow 2003). Few instances of cefepime resistance have been reported. This research used directed molecular evolution involving error-prone rolling circle amplification on plasmids containing the beta-lactamase gene …
-
Η φαρμακοκινητική μελέτη του φουσιδικού οξέος κα της κεφιπίμης στον καρδιακό ιστό, κατά την διάρκεια της εξωσωματικής κυκλοφορίας
… study is the pharmacokinetic behavior of the cefepime and the fusidic acid which antimicrobial spectrum includes gram (+) bacteria, the most common encounter microorganisms in cardiac surgery infections, in myocardium during the extracorporeal circulation.Methods. 2 groups of 15 cardiac …
-
Therapeutic drug monitoring of beta-lacam antibiotics in patients at high risk of therapeutic failure : a pharmacokinetic and pharmacodynamic investigation
… the beta-lactams,piperacillin-tazobactam and cefepime. This Thesis aimed, first through structured and systematic reviews, to describe antibiotic dose optimisation approaches, evidence justifying beta-lactam TDM and how TDM is applied in practice. It then sought to develop a convenient assay …
-
Acute pharmaceutical poisoning as a cause of seizure events: a database analysis (2011–2023)
… were most commonly associated with seizures. Cefepime (37.5%) and bupropion (23.7%) showed the highest seizure potentials. Seizures occurred at low relative overdoses for clozapine, chlorprothixene, and trimipramine (1.3×, 2.0×, 2.8×, respectively). Tricyclic antidepressants (notably …
-
Antimicrobial susceptibility of Acinetobacter isolates from Groote Schuur Hospital region : an investigation of the appropriateness/validity of the NCCLS zone size criteria
… for Acinetobacter species, especially for cefepime (CPIM) and ceftazidime (CT AZ). Since Acinetobacter species contribute significantly to the increased morbidity and mortality of debilitated patients ( especially v entilated ICU patients, and the fact that clinicians rely on the …
-
An Epidemiological and Pharmacokinetic-pharmacodynamic Investigation into the Impact of Carbapenem-resistant Enterobacterales
… CRE using single and combination exposures of cefepime, meropenem, piperacillin/tazobactam, amikacin, and plazomicin along with aztreonam and aztreonam/avibactam. Additionally, we performed a 10-year, inverse probability of treatment weighting adjusted retrospective cohort study comparing the …
-
Colistin for multidrug-resistant Acinetobacter baumannii from Thailand
… resistant to colistin but more susceptible to cefepime, doxycycline, meropenem and rifampicin. These findings suggested the potential of a synergistic activity of colistin combinations. Part 3 was a time-kill study that compared activity of colistin alone and in combination against MDR-A. …
-
Resistance to cephalosporins and carbapenems in gram-negative bacteria isolated from swine, soil, and wastewater of a pig production unit
… 3rd (cefotaxime and ceftriaxone) and 4th (cefepime) generations. The results indicated that 70 % of the isolates from all environments were resistant to imipenem and 20 % to meropenem. Regarding susceptibility to cephalosporins, more than 90 % of the swine and wastewater isolates and more …
-
Microbiologia de aspirado traqueal de crianças traqueostomizadas e sua relação com dados clínicos em um hospital terciário do Brasil
… resistência à gentamicina, à amicacina e ao cefepime em 36% 28% e 12% dos casos, respectivamente. A resistência da P. aeruginosa à gentamicina e ao cefepime teve associação com o número de classes de antibióticos utilizados nos 12 meses precedentes da coleta (ambos p=0,04) e também com o …
-
Beta-lactam antimicrobial dosing optimization in obese patients compared to non-obese patients using population pharmacokinetic/pharmacodynamic approach
… such as piperacillin/tazobactam, meropenem, and cefepime. The objective of this study is to evaluate the population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam, meropenem, and cefepime in hospitalized obese patients in order to determine dosing regimens that provide similar …
-
Molecular characterization of selected pathogens in milk
… pasteurized milk in Zeerust were resistant to Cefepime (33.33%) and Amoxicillin (19.05%). On the contrary, none of the S. aureus isolates was resistant to Aztreonam and Ceftazidime. Similarly, all (100%) the nine PCR confirmed S. agalactiae isolates were resistant to multiple antibiotics. …
-
Antimicrobial Resistance Profiling of Fecal Indicator Bacteria from Poultry in Informal Markets in Maputo, Mozambique
… Trimethoprim-sulfamethoxazole, Ciprofloxacin, Cefepime, Ceftriaxone, Gentamicin, and Tetracycline using Kirby-Bauer disk diffusion susceptibility testing. Market-level differences in AMR outcomes were assessed using Fisher’s exact tests. Hygiene practices were observed using a structured …
-
Perfil epidemiológico y análisis de la formulación antibiótica en pacientes con infección urinaria nosocomial en la Fundación Cardioinfantil en el año 2014
… 90% of the isolates were sensitive to Cefepime. Most models obtained showed a strong association between ESBL report in antibiograma with the formulation of carbapenems as the final therapy OR 33. 12; 95% CI (2. 90 to 337. 4). Conclusion: The epidemiology of nosocomial UTIs in the …
-
Proyecto Opat-Stab: estabilidad de antimicrobianos para administración en programas de tratamiento antibiótico domiciliario endovenoso
… Los antimicrobianos analizados fueron aztreonam, cefepime, cefiderocol, ceftazidima, ceftazidima/avibactam, ceftolozano/tazobactam, meropenem, meropenem/vaborbactam y piperacilina/tazobactam, y las condiciones aplicadas fueron las que se producen comúnmente en los programas TADE. De cada …
-
Antibioticoterapia via oral versus endovenosa em crianças com câncer neutropênicas febris
… via oral e placebo endovenoso e para o grupo B, cefepime e placebo oral. Resultados: Foram selecionados 91 episódios consecutivos de NF em 58 crianças. Para os pacientes do grupo A, a taxa de falência foi de 51,2%, e a média de tempo de hospitalização foi de 8 dias (variação de 2-10). Para os …
-
Perfil clínico e caracterização do uso de medicamentos em cuidados paliativos
… enema de glicerina 12%, metadona, haloperidol, cefepime, codeína, escopolamina, dimenidrinato, glicose 50%, óleo mineral líquido, furosemida, ranitidina, amoxicilina + ácido clavulânico e clorpromazina. O percentual de polifarmácia foi de 94,5%. Conclusões: conhecer a terapia medicamentosa e …
Page 1 of 3